CompanyDrug

Asieris Pharmaceuticals to Present Phase I Results of APL-1202 Combo at ASCO

CompanyDeals

MicroPort Endovascular MedTech Announces Private Placement to Fund Innovation and Expansion

CompanyDrug

Antengene’s ATG-022 Earns FDA Orphan Drug Designations for Gastric and Pancreatic Cancers

Policy / Regulatory

CDE Drafts Proposal on Generic Drug Studies for Varieties without Reference Preparations

CompanyDeals

Mural Health Partners with Clinflash to Enhance Patient Payments in Clinical Trials

CompanyDrug

Hanx Biopharmaceuticals’ HX009 Receives US IND Approval for Lymphoma Treatment

CompanyDeals

Clover Biopharmaceuticals Partners with Kyuan Trade for Commercial Launch of AdimFlu-S (QIS) in China

CompanyDrug

Minghui Pharmaceutical Initiates First-in-Human Trial for IGF-1R Antibody Fusion Protein MHB018A

CompanyDeals

Shanghai Ark Biopharmaceutical Partners with WuXi STA for Commercial Supply of Ziresovir

Policy / Regulatory

China’s NMPA and NHC Tighten Regulations on Tramadol Compound Preparations

CompanyDrug

Sino Biopharmaceutical’s TQ-B3525 Files for Market Approval with CDE

CompanyDrug

MabPharm’s CMAB007 Receives NMPA Approval for IgE-Mediated Asthma Treatment